These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31155302)

  • 1. Stimulation over the cerebellum with a regular figure-of-eight coil induces reduced motor cortex inhibition in patients with progressive supranuclear palsy.
    Benussi A; Dell'Era V; Cantoni V; Turrone R; Pilotto A; Alberici A; Cotelli MS; Rizzetti C; Padovani A; Borroni B
    Brain Stimul; 2019; 12(5):1290-1297. PubMed ID: 31155302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebellar rTMS for motor control in progressive supranuclear palsy.
    Dale ML; DeVries WH; Mancini M; George MS
    Brain Stimul; 2019; 12(6):1588-1591. PubMed ID: 31378601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theta burst stimulation modulates cerebellar-cortical connectivity in patients with progressive supranuclear palsy.
    Brusa L; Ponzo V; Mastropasqua C; Picazio S; Bonnì S; Di Lorenzo F; Iani C; Stefani A; Stanzione P; Caltagirone C; Bozzali M; Koch G
    Brain Stimul; 2014; 7(1):29-35. PubMed ID: 23928103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of long term potentiation-like plasticity in primary motor cortex in patients with progressive supranuclear palsy.
    Bologna M; Bertram K; Paparella G; Papi C; Belvisi D; Conte A; Suppa A; Williams DR; Berardelli A
    Clin Neurophysiol; 2017 Sep; 128(9):1547-1552. PubMed ID: 28704733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discrimination of atypical parkinsonisms with transcranial magnetic stimulation.
    Benussi A; Dell'Era V; Cantoni V; Ferrari C; Caratozzolo S; Rozzini L; Alberici A; Padovani A; Borroni B
    Brain Stimul; 2018; 11(2):366-373. PubMed ID: 29195744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity and Specificity of Diagnostic Criteria for Progressive Supranuclear Palsy.
    Ali F; Martin PR; Botha H; Ahlskog JE; Bower JH; Masumoto JY; Maraganore D; Hassan A; Eggers S; Boeve BF; Knopman DS; Drubach D; Petersen RC; Dunkley ED; van Gerpen J; Uitti R; Whitwell JL; Dickson DW; Josephs KA
    Mov Disord; 2019 Aug; 34(8):1144-1153. PubMed ID: 30726566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholinergic cortical circuits in Parkinson's disease and in progressive supranuclear palsy: a transcranial magnetic stimulation study.
    Nardone R; Florio I; Lochner P; Tezzon F
    Exp Brain Res; 2005 May; 163(1):128-31. PubMed ID: 15754175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive supranuclear palsy.
    Giagkou N; Höglinger GU; Stamelou M
    Int Rev Neurobiol; 2019; 149():49-86. PubMed ID: 31779824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy.
    Borroni B; Malinverno M; Gardoni F; Alberici A; Parnetti L; Premi E; Bonuccelli U; Grassi M; Perani D; Calabresi P; Di Luca M; Padovani A
    Neurology; 2008 Nov; 71(22):1796-803. PubMed ID: 18971445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The frontal assessment battery is not useful to discriminate progressive supranuclear palsy from frontotemporal dementias.
    Stamelou M; Diehl-Schmid J; Hapfelmeier A; Kontaxopoulou D; Stefanis L; Oertel WH; Bhatia KP; Papageorgiou SG; Höglinger GU
    Parkinsonism Relat Disord; 2015 Oct; 21(10):1264-8. PubMed ID: 26324212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP.
    Josephs KA; Petersen RC; Knopman DS; Boeve BF; Whitwell JL; Duffy JR; Parisi JE; Dickson DW
    Neurology; 2006 Jan; 66(1):41-8. PubMed ID: 16401843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pattern of Tau forms in CSF is altered in progressive supranuclear palsy.
    Borroni B; Gardoni F; Parnetti L; Magno L; Malinverno M; Saggese E; Calabresi P; Spillantini MG; Padovani A; Di Luca M
    Neurobiol Aging; 2009 Jan; 30(1):34-40. PubMed ID: 17709155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study.
    Litvan I; Campbell G; Mangone CA; Verny M; McKee A; Chaudhuri KR; Jellinger K; Pearce RK; D'Olhaberriague L
    Brain; 1997 Jan; 120 ( Pt 1)():65-74. PubMed ID: 9055798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebellar dysfunction in progressive supranuclear palsy: a transcranial magnetic stimulation study.
    Shirota Y; Hamada M; Hanajima R; Terao Y; Matsumoto H; Ohminami S; Tsuji S; Ugawa Y
    Mov Disord; 2010 Oct; 25(14):2413-9. PubMed ID: 20818672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive supranuclear palsy presenting as primary lateral sclerosis but lacking parkinsonism, gaze palsy, aphasia, or dementia.
    Nagao S; Yokota O; Nanba R; Takata H; Haraguchi T; Ishizu H; Ikeda C; Takeda N; Oshima E; Sakane K; Terada S; Ihara Y; Uchitomi Y
    J Neurol Sci; 2012 Dec; 323(1-2):147-53. PubMed ID: 23026537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from Parkinson's disease.
    Nicoletti G; Tonon C; Lodi R; Condino F; Manners D; Malucelli E; Morelli M; Novellino F; Paglionico S; Lanza P; Messina D; Barone P; Morgante L; Zappia M; Barbiroli B; Quattrone A
    Mov Disord; 2008 Dec; 23(16):2370-6. PubMed ID: 18816803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Corticobasal degeneration and atypical progressive supranuclear palsy: their symptomatology, laboratory examination and differential diagnosis].
    Morimatsu M; Negoro K; Mori H
    Rinsho Shinkeigaku; 2004 Nov; 44(11):982-5. PubMed ID: 15651349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyramidal system involvement in progressive supranuclear palsy - a clinicopathological correlation.
    Stejskalova Z; Rohan Z; Rusina R; Tesar A; Kukal J; Kovacs GG; Bartos A; Matej R
    BMC Neurol; 2019 Mar; 19(1):42. PubMed ID: 30894142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of clinical diagnosis of progressive supranuclear palsy.
    Osaki Y; Ben-Shlomo Y; Lees AJ; Daniel SE; Colosimo C; Wenning G; Quinn N
    Mov Disord; 2004 Feb; 19(2):181-9. PubMed ID: 14978673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotypic behaviours in frontotemporal dementia and progressive supranuclear palsy.
    Prioni S; Redaelli V; Soliveri P; Fetoni V; Barocco F; Caffarra P; Scaglioni A; Tramacere I; Girotti F
    Cortex; 2018 Dec; 109():272-278. PubMed ID: 30399478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.